Eugene R. Schiff, MD
Disclaimer: The author has served as principal investigator, co-investigator, scientific advisor, or speaker for numerous pharmaceutical firms, many of which are competitors in the marketplace.
Requests for Single Reprints: Eugene R. Schiff, MD, Division of Hepatology, Center for Liver Diseases, Suite 1101, Miami, FL 33136; e - mail, email@example.com.
Requests To Purchase Bulk Reprints (minimum, 100 copies): the Reprints Coordinator; phone, 215-351-2657; e-mail, firstname.lastname@example.org.
Schiff E.; Update in Hepatology. Ann Intern Med. 2000;132:460-466. doi: 10.7326/0003-4819-132-6-200003210-00006
Download citation file:
Published: Ann Intern Med. 2000;132(6):460-466.
Among the wide range of reports on hepatologic issues published in 1998, I address key research in the areas of viral hepatitis, drug-induced hepatotoxicity, and noninvasive diagnostic assessment using magnetic resonance cholangiography.
For practical purposes, the dominant forms of hepatitis in the United States are A, B, and C. The D (“delta”) hepatitis virus is becoming less prevalent throughout the world. Hepatitis E remains a major problem in developing countries worldwide but is rare in this country. Other viruses—hepatitis G among them—have been described but are not clinically important. There is some question of whether they should even be classified as hepatitis viruses; they have not been convincingly connected with acute or chronic liver disease. The papers I have selected deal with hepatitis A, both in epidemic form and as a superinfection in patients with chronic hepatitis B or C. In addition, I discuss results from a large multicenter trial that examined the value of adding ribavirin to interferon as initial treatment for chronic hepatitis C.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only